David Benjamin Kohn, PA-C

David Kohn practices at Mindpath Health Florida in Ocoee, Florida.

David Kohn's NPI, 1720556178, was assigned on November 4, 2018. David Kohn holds Florida license PA9111412.

David Kohn's primary practice is Mindpath Health Florida, at 1540 Citrus Medical Ct, Ocoee, FL 34761 in Orange County. The practice phone is (954) 227-2700.

David Kohn's primary practice is Mindpath Health Florida in Ocoee, Florida. The medical group on file is Mindpath Health. Dmand AI also links David Kohn to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where David Kohn practices. Vendor and product names are available with a free account.

Physician assistant is David Kohn's primary specialty in the NPI Registry, under taxonomy code 363A00000X. David Kohn is licensed in Florida.

Dmand AI lists ADHD, alcohol use disorders, anxiety, bipolar disorder, depression, insomnia and schizophrenia among the conditions David Kohn treats.

CMS data shows 359 Medicare services from David Kohn across 2 procedure codes in 2024, for 38 Medicare patients. Medicare paid $22,751 for them. Every service was in an office.

CMS counts 38 Medicare patients who saw David Kohn in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have anxiety, and 75% have depression. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts David Kohn's median patient age at 43, with 53% women.

In 2024, David Kohn wrote 1,322 Medicare Part D claims for 109 patients. 97% of them were for generic drugs. CMS names the drug for 1,171 of them, across 22 drugs with 11 or more claims each, at $13,426 in total drug cost.

David Kohn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists David Kohn as offering telehealth.

CMS Open Payments shows 105 general payments to David Kohn from 20 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Axsome Therapeutics, Inc. paid the most, $273.